Clinical trial

TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

NCT00789997

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2008-11-01Date precision: month

Registry last updated2016-04-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPD Exacerbationunresolved

Interventions

PrednisoneDRUG · verified · RxNorm: prednisone

EtanerceptDRUG · verified · RxNorm: etanercept

levofloxacinDRUG · verified · RxNorm: levofloxacin

Sponsors & collaborators

Ottawa Hospital Research Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00789997 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.